Closing report: Boosting the development of medicines for children

Regulators in the European Union (EU) have taken several initiatives in the past four years to increase the efficiency of paediatric regulatory processes and boost the development of medicines for children. These achievements are highlighted in the closing report of the EMA and European Commission (EC) action plan on paediatrics
Some of the key improvements brought by the paediatric action plan include:
• Strengthened focus on unmet medical needs
• Adapting regulatory processes to better support innovation
• Increased alignment of data requirements between decision-makers.
For more details please check out the report here.